Bethesda, MD12 Active Studies

Fanconi Anemia Clinical Trials in Bethesda, MD

Find 12 actively recruiting fanconi anemia clinical trials in Bethesda, MD. Connect with local research sites and explore new treatment options.

12
Active Trials
7
Sponsors
12,787
Enrolling

Recruiting Fanconi Anemia Studies in Bethesda

About Fanconi Anemia Clinical Trials in Bethesda

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 12 fanconi anemia clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 12,787 participants. Research is being sponsored by National Human Genome Research Institute (NHGRI), National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID) and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Bethesda — FAQ

Are there fanconi anemia clinical trials in Bethesda?

Yes, there are 12 fanconi anemia clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 12 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 19, 2026 from ClinicalTrials.gov